T
RGEN icon

TOBAM’s Repligen RGEN Stock Holding History

TOBAM’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-341
Closed -$54K – 400
2023
Q3 		$54K Sell
341
-465
-58% -$76K ﹤0.01% 329
2023
Q2 		$114K Buy
806
+335
+71% +$53.7K 0.01% 300
2023
Q1 		$79K Sell
471
-858
-65% -$153K 0.01% 312
2022
Q4 		$225K Sell
1,329
-581
-30% -$105K 0.01% 194
2022
Q3 		$357K Sell
1,910
-578
-23% -$122K 0.03% 170
2022
Q2 		$404K Buy
2,488
+2,228
+857% +$352K 0.03% 179
2022
Q1 		$49K Buy
260
+84
+48% +$16K ﹤0.01% 391
2021
Q4 		$47K Hold
176
– – ﹤0.01% 362
2021
Q3 		$51K Hold
176
– – ﹤0.01% 355
2021
Q2 		$35K Hold
176
– – ﹤0.01% 407
2021
Q1 		$34K Hold
176
– – ﹤0.01% 407
2020
Q4 		$34K Buy
+176
New +$32K ﹤0.01% 393

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TOBAM's RGEN Position: Q4 2023 in Review

TOBAM sold out of Repligen (RGEN) in Q4 2023, closing a stake of 341 shares — an estimated $54K sold.

TOBAM first reported a position in RGEN in Q4 2020 and held it in 12 quarters. The position peaked at $404K in Q2 2022. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • TOBAM reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • TOBAM sold 341 Repligen shares in Q4 2023, an estimated $54K.
  • TOBAM first reported a position in Repligen in Q4 2020 and held it in 12 quarters.
  • TOBAM's Repligen position peaked at $404K in Q2 2022.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on TOBAM's 13F filing for Q4 2023, filed 26 Jan 2024.